Deucravacitinib long-term efficacy and safety in plaque psoriasis: 2-year results from the phase 3 POETYK PSO program

被引：0

作者：

Spelman, Lynda ^{[1
]}

Warren, Richard B. ^{[2
]}

Sofen, Howard ^{[3
]}

Imafuku, Shinichi ^{[4
]}

Blauvelt, Andrew ^{[5
]}

Toms, Jessica ^{[6
]}

Buck, Alex ^{[7
]}

Banerjee, Subhashis ^{[6
]}

Menter, Alan ^{[8
]}

Szepietowski, Jacek C. ^{[9
]}

机构：

[1] Verac Clin Res, Brisbane, Qld, Australia

[2] Univ Manchester, Salford Royal NHS Fdn Trust, Dermatol Ctr, Manchester NIHR Biomed Res Ctr, Manchester, Lancs, England

[3] Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA

[4] Fukuoka Univ Hosp, Fukuoka, Japan

[5] Oregon Med Res Ctr, Portland, OR USA

[6] Bristol Myers Squibb, New York, NY USA

[7] Cytel Inc, Bristol Myers Squibb, Dallas, TX USA

[8] Baylor Univ, Med Ctr, Waco, TX 76798 USA

[9] Wroclaw Med Univ, Wroclaw, Poland

来源：

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：28 / 28

页数：1